Instalab
logoInstalab

TUB Genotype

Find out if you carry an inherited variant in a brain gene linked to early weight gain, vision loss, or tremor.
4.9 (4,628 reviews)
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Collect your sample
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a TUB test?

This test is most useful if any of these apply to you.

Weight That Runs in Your Family
If serious weight struggles started young in your family, a TUB variant may help explain why standard advice has not been enough.
Inherited Vision Loss in Your Family
If a parent, sibling, or child has unexplained retinal disease, this test checks one of the rare genes tied to inherited vision loss.
Tremor That Runs in Your Family
If essential tremor shows up across generations, a TUB variant may be part of the inheritance pattern your family is seeing.
Healthy but Want to Know Your Inherited Risks
If your labs look fine and you want a fuller picture of what you may have inherited, this adds one piece to the genetic map.

About TUB Genotype

If weight gain started young in your family, if a relative has unexplained vision loss, or if tremor runs in your bloodline, your TUB gene may hold a clue. Most adults will never need to think about this gene. For a small group of families, though, a variant here can help explain a pattern that the usual story (eat less, move more) does not match.

This test reads the DNA at the TUB (tubby) gene to look for inherited changes that have been tied to three very different conditions: severe early-onset obesity, a rare inherited retinal disease, and a familial form of essential tremor. The science is still maturing, so think of this as one early signal in a broader genetic picture, not a definitive verdict.

What the TUB Gene Does

TUB takes its name from a mouse strain that became obese when this gene was disrupted. In humans, TUB makes a protein that is most active in the hypothalamus, the appetite control center deep in your brain. There it helps brain cells respond to leptin, the hormone that signals when you have eaten enough.

TUB also plays a role in tiny hair-like structures on the surface of cells called cilia, which are especially important in the light-sensing cells of the retina. The same protein is active in the brain's cerebellum, the region that coordinates smooth movement. That broad reach across appetite, vision, and movement is why a single gene shows up in three very different stories.

Early-Onset and Adult Obesity Risk

The strongest TUB story is about body weight. In a large East Asian study of young-onset obesity, people carrying a rare loss-of-function variant in TUB (a change that breaks the gene, abbreviated LoF) were more likely to develop obesity at a young age. In mice carrying the same change, the animals overate, gained weight, and stopped responding normally to leptin in the appetite-regulating neurons of the brain.

Common variants tell a more subtle story. In Dutch adults with type 2 diabetes, three single-letter DNA changes (a type of variant called a SNP, short for single nucleotide polymorphism) named rs1528133, rs2272382, and rs2272383 were linked to higher BMI (body mass index, a weight-for-height score). In middle-aged Dutch women, the same variants were tied to higher body weight and higher carbohydrate intake, suggesting an effect on eating behavior, not just metabolism.

In postmenopausal women, the rs2272382 variant was tied to more general and central (belly) fat, supporting the idea that TUB acts more like a late-onset obesity gene than a childhood one for most carriers. In a study of Hispanic and Latino adults, rs2272383 carriers were about 34% more likely to have obesity (odds ratio 1.34, 95% confidence interval 1.04 to 1.71), though this signal did not survive the strictest statistical correction.

Who Was StudiedWhat Was ComparedWhat They Found
About 4,600 East Asian adults with young-onset obesity and lean controlsCarriers of a rare TUB loss-of-function variant vs non-carriersCarriers were more likely to develop obesity early in life, and in animal models the variant disrupted normal appetite signaling
About 1,100 African American and Hispanic/Latino adultsCarriers of TUB rs2272383 vs non-carriersHispanic/Latino carriers were about 34% more likely to have obesity
About 2,700 women (roughly 1,150 postmenopausal)Carriers of TUB rs2272382 vs non-carriersPostmenopausal carriers had more general and belly fat

What this means for you: if you carry a TUB variant tied to obesity, the gene is likely shaping how your brain reads the leptin signal, which can make sustained weight loss harder. It does not mean weight management is impossible. It means standard advice may not be enough, and intensive nutrition support, sleep work, or newer weight-lowering medications may have more to offer than they would for someone without this background.

Inherited Retinal Disease

When both copies of the TUB gene are broken by truncating or splice-disrupting variants (so-called biallelic inactivating variants), the result is a rare inherited retinal disease. Affected people develop progressive vision loss because the light-sensing cells of the retina cannot build and maintain their cilia properly. Some carriers also have obesity, linking the gene's two main roles in a single condition.

A broader screen of TUB in people with retinitis pigmentosa and Leber congenital amaurosis (two inherited eye diseases) found several single-copy variants, but none could be firmly tied to a specific eye disease on its own. That pattern fits a recessive condition: usually two faulty copies are required for serious eye disease to develop, while carrying just one copy is generally not enough.

Essential Tremor Risk

Rare protein-changing TUB variants, including one called p.V431I, are more common in people with essential tremor than in the general population. Essential tremor is the most common adult movement disorder, often running in families, and shows up as a rhythmic shake of the hands, head, or voice. Lab work suggests TUB helps regulate signals in the cerebellum that affect neurotransmitter production and thyroid hormone activity in brain tissue.

What this means for you: a TUB variant alone does not cause tremor in everyone who carries it, but in families where tremor is already present, finding a variant may help explain the inheritance pattern and inform conversations with biological relatives.

One-Time Result, Lifetime Information

Your DNA sequence at TUB does not change. This is a once-in-a-lifetime test. You do not need to repeat it unless the lab recommends a confirmatory method (for example, Sanger sequencing after an initial chip-based result), or unless newer testing platforms cover variants that were not on the original panel.

The ongoing tracking happens with the phenotypes (the body measurements and conditions) the gene influences. If you carry a TUB variant tied to weight, that argues for more frequent metabolic checks: BMI, waist circumference, fasting glucose, HbA1c (a 3-month average of blood sugar), fasting insulin, and a lipid panel at least once a year. If your variant is tied to the retinal form, regular eye exams with a retinal specialist matter more than another DNA test. If tremor is the concern, ongoing neurological follow-up is more useful than retesting the gene.

When Results Can Be Misleading

  • Variant panel coverage: the assay only finds the specific changes it is built to look for. A negative result does not rule out other rare variants in TUB that the panel does not cover.
  • Ancestry-specific frequencies: some TUB variants are more common in certain populations and rarer in others, so the clinical meaning of a result depends on your ancestry. Most TUB studies have been done in European, East Asian, and a few mixed-ancestry groups, which limits how confidently results can be interpreted in people from underrepresented backgrounds.
  • Variant of uncertain significance: an unexpected change in TUB may be reported with unknown clinical meaning. This is not a positive or a negative; it is a flag for future re-review as more data accumulate.
  • Clinical-grade vs direct-to-consumer testing: ancestry-style services may report on a single TUB SNP without confirming it by a second method. Treat those calls as a screening signal, not a clinical diagnosis.

What an Unexpected Result Should Make You Do

A flagged TUB result is not a diagnosis. It is a reason to look more carefully at the body system the variant touches. If your variant is in the obesity-linked group, the next step is a thorough metabolic workup: fasting glucose and insulin, HbA1c, a full lipid panel including ApoB (a count of harmful cholesterol-carrying particles), liver enzymes, and a conversation about evidence-based weight management options including GLP-1 receptor agonists and structured nutrition support.

If your variant is in the retinal group (especially if both copies of the gene are affected) ask for a referral to an ophthalmologist with experience in inherited retinal disease. If tremor runs in your family, share the result with a neurologist who can place it in the context of a full neurological exam. In every case, a genetic counselor can help you decide which biological relatives might benefit from testing and how to talk to them about it.

Frequently Asked Questions

References

10 studies
  1. Sailani MR, Jahanbani F, Abbott CW, Lee H, Zia a, Rego S, Winkelmann J, Hopfner F, Khan T, Katsanis N, Müller SH, Berg D, Lyman K, Mychajliw C, Deuschl G, Bernstein J, Kuhlenbäumer G, Snyder MPLoS Genetics2020
  2. Chalazan B, Palm D, Sridhar a, Lee C, Argos M, Daviglus M, Rehman J, Konda S, Darbar DPLoS ONE2020
  3. Ziccardi L, Niceta M, Stellacci E, Ciolfi a, Tatti M, Bruselles a, Mancini C, Barbano L, Cecchetti S, Costanzo E, Cappa M, Parravano M, Varano M, Tartaglia M, Cordeddu VInternational Journal of Molecular Sciences2022
  4. Shiri-sverdlov R, Custers a, Van Vliet-ostaptchouk JV, Van Gorp PJ, Lindsey P, Van Tilburg JV, Zhernakova S, Feskens E, Van Der a D, Dollé M, Van Haeften TV, Koeleman B, Hofker M, Wijmenga CDiabetes2006
  5. Van Vliet-ostaptchouk JV, Onland-moret NC, Shiri-sverdlov R, Van Gorp PJ, Custers a, Peeters PHM, Wijmenga C, Hofker MH, Van Der Schouw YTPLoS ONE2008